ADA issues key updates to two diabetes guidelines
Diabetes is estimated to affect approximately 33% of adults aged 65 years and older, and almost 50% of older adults meet the criteria for prediabetes. Recent updates to diabetes guidelines from the American Diabetes Association (ADA) and the Endocrine Society are geared toward providing optimal care to patients with diabetes.
In March 2019, ADA issued key updates to its 2019 Standards of Medical Care in Diabetes that focused on CV and renal health. The updates are included as annotations in a “living” document known as “Living Standards of Care” and are based on data from REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial) and the DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events–Thrombosis in Myocardial Infarction 58) trial.
“These updates via the online annotations to our yearly Standards of Care enable us to translate and communicate significant research findings that will empower health professionals to provide optimal care for millions of Americans living with diabetes,” said William T. Cefalu, MD, ADA’s chief scientific, medical, and mission officer in an ADA press release.
In May 2019, the Endocrine Society, in association with the European Society of Endocrinology, the Gerontological Society of America, and the Obesity Society, published a clinical practice guideline on management of diabetes in older adults (i.e., ≥65 y). This guideline aims to simplify medication regimens and tailor glycemic targets in older adults with diabetes to improve adherence and avoid treatment-related complications.
“The [Endocrine Society] guideline encourages clinicians to consider available evidence and a patient’s overall health, likelihood to benefit from interventions and personal values when considering treatment goals such as glucose, blood pressure, and cholesterol,” said Derek LeRoith, MD, PhD, chair of the guideline committee, in a press release from the Endocrine Society.
For the full article, please visit www.pharmacytoday.org for the June 2019 issue of Pharmacy Today.